The Pennant Group, Inc. (PNTG)
USD 26.03
(2.6%)
USD 26.03
(2.6%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 323.57 Million USD | -0.28% |
| 2022 | 324.48 Million USD | -7.3% |
| 2021 | 350.05 Million USD | 9.75% |
| 2020 | 318.95 Million USD | -4.63% |
| 2019 | 334.45 Million USD | 815839.02% |
| 2018 | -41 Thousand USD | -13.89% |
| 2017 | -36 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 349.21 Million USD | 2.07% |
| 2024 Q1 | 342.13 Million USD | 5.74% |
| 2023 Q3 | 316.31 Million USD | -1.16% |
| 2023 Q4 | 323.57 Million USD | 2.29% |
| 2023 FY | 323.57 Million USD | -0.28% |
| 2023 Q1 | 320.96 Million USD | -1.08% |
| 2023 Q2 | 320.03 Million USD | -0.29% |
| 2022 Q4 | 324.48 Million USD | 1.98% |
| 2022 Q1 | 328.34 Million USD | -6.2% |
| 2022 FY | 324.48 Million USD | -7.3% |
| 2022 Q3 | 318.17 Million USD | 2.57% |
| 2022 Q2 | 310.21 Million USD | -5.52% |
| 2021 Q2 | 341.62 Million USD | 4.08% |
| 2021 FY | 350.05 Million USD | 9.75% |
| 2021 Q4 | 350.05 Million USD | 2.45% |
| 2021 Q3 | 341.67 Million USD | 0.01% |
| 2021 Q1 | 328.22 Million USD | 2.91% |
| 2020 Q1 | 339.08 Million USD | 1.38% |
| 2020 Q2 | 302.5 Million USD | -10.79% |
| 2020 FY | 318.95 Million USD | -4.63% |
| 2020 Q4 | 318.95 Million USD | 4.86% |
| 2020 Q3 | 304.17 Million USD | 0.55% |
| 2019 Q1 | 225.89 Million USD | 551051.22% |
| 2019 FY | 334.45 Million USD | 815839.02% |
| 2019 Q4 | 334.45 Million USD | 38.8% |
| 2019 Q3 | 240.95 Million USD | 0.58% |
| 2019 Q2 | 239.56 Million USD | 6.05% |
| 2018 Q4 | -41 Thousand USD | 0.0% |
| 2018 Q1 | 36 Thousand USD | 0.0% |
| 2018 FY | -41 Thousand USD | -13.89% |
| 2017 FY | -36 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 77.062% |
| Addus HomeCare Corporation | 110.39 Million USD | -193.115% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | -261.914% |
| Amedisys, Inc. | 341.35 Million USD | 5.208% |
| American Oncology Network, Inc. | 99.78 Million USD | -224.267% |
| Astrana Health, Inc. | 27.2 Million USD | -1089.301% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 77.765% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | 146175.364% |
| biote Corp. | 25.86 Million USD | -1150.814% |
| Cryo-Cell International, Inc. | 10.48 Million USD | -2984.596% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 2835.884% |
| COMPASS Pathways plc | -187.58 Million USD | 272.491% |
| DocGo Inc. | -12.78 Million USD | 2630.088% |
| The Ensign Group, Inc. | 1.36 Billion USD | 76.237% |
| Healthcare Services Group, Inc. | -10.69 Million USD | 3125.46% |
| InnovAge Holding Corp. | 56.08 Million USD | -476.892% |
| Assure Holdings Corp. | 14.68 Million USD | -2103.875% |
| The Joint Corp. | -2.47 Million USD | 13150.14% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 25.137% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | 5447.817% |
| ModivCare Inc. | 1.13 Billion USD | 71.549% |
| NewGenIvf Group Limited | 278.44 Thousand USD | -116105.481% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | -7878.964% |
| Option Care Health, Inc. | 822.56 Million USD | 60.663% |
| P3 Health Partners Inc. | 83.7 Million USD | -286.554% |
| P3 Health Partners Inc. | 83.7 Million USD | -286.554% |
| Surgery Partners, Inc. | 2.86 Billion USD | 88.709% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | 10772.031% |
| Talkspace, Inc. | -123.9 Million USD | 361.14% |
| Talkspace, Inc. | -123.9 Million USD | 361.14% |
| The Oncology Institute, Inc. | 86.32 Million USD | -274.822% |
| The Oncology Institute, Inc. | 86.32 Million USD | -274.822% |